𝔖 Bobbio Scriptorium
✦   LIBER   ✦

14b-Chloro-4a-methoxy-3,3-dimethyl-2,3,4a,14b-tetrahydro-1H-benzo[a]pyrano[2,3-c]phenazine: a new active structural type against Mycobacterium tuberculosis

✍ Scribed by Nunes, I. K. da C. ;De Simone, C. A. ;Silva, R. S. F. ;Pinto, A. V. ;Goulart, M. O. F.


Book ID
104491436
Publisher
International Union of Crystallography
Year
2007
Tongue
English
Weight
763 KB
Volume
63
Category
Article
ISSN
1600-5368

No coin nor oath required. For personal study only.

✦ Synopsis


The title compound, C 22 H 21 ClN 2 O 2 , obtained from the reaction of the phenazine of -lapachone with trichloroisocyanuric acid, showed a minimum inhibitory concentration of 6.25 ng ml À1 in tuberculostatic assays against Mycobacterium tuberculosis and established a new structural type with potential interest in medicinal chemistry. The dihydropyran ring adopts a pure chair conformation, while the ring fused to it has a half-chair conformation. The two substituents, OMe and Cl, are in axial positions, due to anomeric effects towards the methoxy derivative.

Related literature

For general background, see:


📜 SIMILAR VOLUMES


4,4-Dimethyl-2-tosyl-2,3,3a,4-tetrahydro
✍ Chinnakali, K. ;Sudha, D. ;Jayagopi, M. ;Raghunathan, R. ;Fun, Hoong-Kun 📂 Article 📅 2007 🏛 International Union of Crystallography 🌐 English ⚖ 811 KB

The molecule of the title compound, C~23~H~23~NO~4~S, adopts a folded conformation, with the cyclopentadienone ring and tosyl groups arranged in an almost face-to-face fashion. The pyrrolidine ring has an envelope conformation and the dihydropyran ring is in a half-chair conformation. The pyrrolidin

Synthesis of 14C-labelled (S)-(+)-6-(2-c
✍ Shuhei Miyazawa; Kazuo Okano; Kazutomi Kusano; Kyoichi Tadano; Shigeru Tanaka; T 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 197 KB 👁 1 views

## Abstract ^14^C‐Labelled (S)‐(+)‐6‐(2‐chlorophenyl)‐3‐cyclopropanecarbonyl‐8,11‐dimethyl‐2,3,4,5‐ tetrahydro‐8H‐pyrido[4′,3′:4,5]thieno[3,2‐f][1,2,4]triazolo[4,3‐a][1,4] diazepine (^14^C‐E6123), a platelet activating factor receptor antagonist for studying the pharmacokinetic profile of E6123, wa